MD Anderson's The Art and Science of Managing the New Melanoma Landscape 2020
L

MD Anderson 2020 Updates on Melanoma Outcome Modeling: Tcategory & Ncategory Definition & Usage, Adjuvant Therapy Impact, CNS Metastases

By MD Anderson's The Art and Science of Managing the New Melanoma Landscape 2020 FEATURING Lauren Haydu
By MD Anderson's The Art and Science of Managing the New Melanoma Landscape 2020 FEATURING Lauren Haydu
0 views
November 19, 2020
Comments 0
Login to view comments. Click here to Login

Recommended

AUTOPLAY
20:09
Scripps Health

Dysplastic Nevi: Navigating the Risk Landscape

Feat. B. Kelley
12:46
Stanford Medicine

FDA Approval of Lifileucel for Unresectable or Metastatic Melanoma: …

Feat. A. Betof Warner
24:14
Masterclasses in Dermatology

Advances in the Treatment of Melanoma

Feat. D. Fisher
20:10
Scripps Health

Melanonychia Diagnosis, Evaluation, and Treatment

Feat. F. Fish
13:58
Dana-Farber Cancer Institute

Lynch Syndrome and Skin: A Dermatologist’s Perspective

Feat. V. Nambudiri
29:26
Scripps Health

Sun Exposure and Melanoma: Connecting the Dots

Feat. D. Kent
08:41
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "NADINA Trial - Neoadjuvant Nivo + Ipi in …

Feat. C. Blank
03:55
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "COMBI-AD Study - Dabrafenib + Trametinib …

Feat. A. Hauschild
24:29
Scripps Health

2024 Update on Melanoma, the Primary Lesion: Biopsy, Excision, and M…

Feat. D. Kent
24:40
Scripps Health

Pathology of Melanoma

Feat. B. Kelley
25:44
Scripps Health

Melanoma in the Molecular Age - Part 1: New Tools for Diagnosis, Pro…

Feat. G. Hosler
24:27
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Highlights in Melanoma - Neoadjuvant and A…

Feat. Z. Eroglu
52:19
Winship Melanoma and Cutaneous Oncology Symposium

2024 Updates on Neoadjuvant Therapy for Resectable Melanoma

Feat. S. Patel
23:57
Scripps Health

Innovations in Diagnostic Techniques for Melanoma

Feat. T. Blalock
13:12
2023 Year in Review

Year in Review: Surgical Treatment of Acral Melanoma

Feat. M. Leventer
21:12
Robert Swerlick

Dealing With Melanoma Overdiagnosis: Can We Find an Off-Ramp?

22:58
Tarek Haykal

The Role of Adjuvant IO vs. Targeted Therapy for BRAF V600-Mutant St…

18:15
Scripps Health

Ocular and Periocular Melanoma: 2024 Updates

Feat. G. Mannor
14:01
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Macroscopic Stage III Melanoma and Immuno…

Feat. H. Kluger
14:23
Alexander Van Akkooi

Advantages & Disadvantages of Adjuvant IO vs. Targeted Treatment…